Zobrazeno 1 - 10
of 133
pro vyhledávání: '"M Roßow"'
Autor:
Michelle Liu, Katelyn M. Rossow, Angela C. Maxwell‐Horn, Leigh Ann Saucier, Sara L. Van Driest
Publikováno v:
Pharmacotherapy.
Pharmacogenetic testing for psychiatry is growing at a rapid pace, with multiple sites utilizing results to help clinical decision-making. Genotype-guided dosing and drug selection have been implemented at several sites, including Vanderbilt Universi
Publikováno v:
Pediatric Research. 91:529-538
This review evaluates the pediatric evidence for pharmacogenetic associations for drugs that are commonly prescribed by or encountered by pediatric clinicians across multiple subspecialties, organized from most to least pediatric evidence. We begin w
Publikováno v:
Journal of Trainology. 8:27-30
Publikováno v:
Medicine & Science in Sports & Exercise. 54:597-597
Autor:
Lindy M. Rossow
Publikováno v:
Medicine & Science in Sports & Exercise. 54:522-522
Publikováno v:
Pharmacogenomics. 22(8)
Tweetable abstract High-quality studies examining the influence of CYP2D6 on the exposure and tolerability of antipsychotics in youth are needed to mitigate the limitations of prior studies.
Autor:
Jeremy P Loenneke, Christopher A Fahs, Lindy M Rossow, Robert S Thiebaud, Kevin T Mattocks, Takashi eAbe, Michael G Bemben
Publikováno v:
Frontiers in Physiology, Vol 4 (2013)
Externí odkaz:
https://doaj.org/article/6d65b290e8f84506aafc13168b0ad44a
Publikováno v:
Pediatrics
OBJECTIVES: To determine the association between cytochrome P450 2C19 (CYP2C19) metabolizer status and risk for escitalopram and citalopram, collectively termed (es)citalopram, and sertraline adverse events (AEs) in children. METHODS: In this retrosp
Publikováno v:
Pediatric research. 91(3)
This review evaluates the pediatric evidence for pharmacogenetic associations for drugs that are commonly prescribed by or encountered by pediatric clinicians across multiple subspecialties, organized from most to least pediatric evidence. We begin w
Autor:
Dan M. Roden, Angela C. Maxwell-Horn, Sara L. Van Driest, Kazeem A Oshikoya, Katelyn M. Rossow, Ida Aka
Publikováno v:
J Dev Behav Pediatr
Objective To determine the association between genetic variants reported to affect risperidone and adverse events (AEs) in children and adolescents. Methods Individuals aged 18 years or younger with ≥4 weeks of risperidone exposure in a deidentifie